Abstract: A system and method for preparing a microbial supplement, and applying the supplement to plants, trees and other items to promote their growth. The supplement comprises seawater, including microbes that naturally exist in seawater. Seawater is harvested containing microbes in an inactive or dormant state. The seawater undergoes a filtration, mineralization and oxygenation process to reduce sodium chloride levels, to increase the levels of desirable minerals in the seawater and to oxygenate the seawater to keep the microbes alive, though in a dormant or inactive state. The microbes are maintained in an inactive or dormant state through the preparation process, but become active when the supplement is applied to plants or trees, thereby promoting agricultural growth.

Abstract: The disclosure relates to a composting device including a housing defining an interior, and having a top wall defining an access opening providing access to the interior, a door moveable relative to the access opening between open/closed positions to selectively open/close the access opening, a trim bezel with a trim bezel opening, and a bin located within the interior and having a fill opening in communication with the trim bezel opening.

Abstract: One or more embodiments of the present invention provide an oxidized glutathione-containing solid composition which can be produced by a simple method and has low deliquescence and is easy to handle. One or more embodiments of the present invention relate to a solid composition comprising an amorphous oxidized glutathione and a water-soluble cellulose derivative. One or more embodiments of the present invention also relate to a method for producing the solid composition comprising an amorphous oxidized glutathione and a water-soluble cellulose derivative, comprising a step of drying a solution comprising oxidized glutathione and a water-soluble cellulose derivative dissolved in an aqueous solvent.

Abstract: An integrated process for maximizing recovery of aromatics is provided. The process comprises passing at least a portion of a xylene column bottoms stream to a heavy aromatics column to provide a heavy aromatics column bottoms stream comprising C9+ aromatics and a heavy aromatics column overhead stream. The heavy aromatics column bottoms stream is passed to a second stage hydrocracking reactor of a two-stage hydrocracking reactor. In the second stage hydrocracking reactor, the heavy aromatics column bottoms stream is hydrocracked in the presence of a hydrocracking catalyst and hydrogen to provide a hydrocracked effluent stream.

Abstract: A method of preparing hydrodesulfurization catalysts having cobalt and molybdenum sulfide deposited on a support material containing mesoporous silica. The method utilizes a sulfur-containing silane that dually functions as a silica source and a sulfur precursor. The method involves an one-pot strategy for hydrothermal treatment and a single-step calcination and sulfidation procedure. The application of the hydrodesulfurization catalysts in treating a hydrocarbon feedstock containing sulfur compounds to produce a desulfurized hydrocarbon stream is also specified.

Abstract: A hydrodesulfurization catalyst, which includes (i) a catalyst support including a zeolite doped with 0.1 to 0.5 wt. % of a graphene material, based on a total weight of the catalyst support, (ii) 5 to 20 wt. % of molybdenum, based on a total weight of the hydrodesulfurization catalyst, and (iii) 1 to 6 wt. % of a promoter selected from the group consisting of cobalt and nickel, based on a total weight of the hydrodesulfurization catalyst. The molybdenum and the promoter are homogeneously disposed on the catalyst support. A method of producing the hydrodesulfurization catalyst via incipient wetness impregnation techniques, and a method for desulfurizing a hydrocarbon feedstock with the hydrodesulfurization catalyst are also provided.

Abstract: A process for preparing a hydrocarbon fluid includes a step of oligomerising an initial hydrocarbon composition which contains, in relation to the total weight of said initial hydrocarbon composition, at least 2% by weight of 3-methyl-but-1-ene, at least 5% by weight of 2-methyl-but-2-ene and at least 5% by weight of 2-methyl-but-1-ene.

Abstract: The present disclosure provides oxidative coupling of methane (OCM) systems for small scale and world scale production of olefins. An OCM system may comprise an OCM subsystem that generates a product stream comprising C2+ compounds and non-C2+ impurities from methane and an oxidizing agent. At least one separations subsystem downstream of, and fluidically coupled to, the OCM subsystem can be used to separate the non-C2+ impurities from the C2+ compounds. A methanation subsystem downstream and fluidically coupled to the OCM subsystem can be used to react H2 with CO and/or CO2 in the non-C2+ impurities to generate methane, which can be recycled to the OCM subsystem. The OCM system can be integrated in a non-OCM system, such as a natural gas liquids system or an existing ethylene cracker.

Abstract: The present disclosure provides natural gas and petrochemical processing systems including oxidative coupling of methane reactor systems that integrate process inputs and outputs to cooperatively utilize different inputs and outputs of the various systems in the production of higher hydrocarbons from natural gas and other hydrocarbon feedstocks.

Abstract: The present invention provides a production method for indene, comprising a dehydrogenation step of obtaining a reaction product containing indene by contacting a raw material gas containing indane and molecular hydrogen with a dehydrogenation catalyst, wherein the dehydrogenation catalyst comprises a support containing aluminum, and a supported metal supported on the support, the supported metal contains a group 14 metal element and platinum, and an atomic ratio of the group 14 metal element to the platinum in the dehydrogenation catalyst is 8.0 or less.

Abstract: The present description relates to heptane obtained from a plant source, wherein the plant source comprises Commiphora wildii. Uses of said heptane in perfumery, cosmetics and food flavoring are also described.

Abstract: The present invention provides processes for the preparation of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a salt or solvate thereof and novel intermediates used therein. In some embodiments the 3,5-Dihydroxy-4-isopropyl-trans-stilbene is prepared from (E)-2-chloro-2-isopropyl-5-styrylcyclohexane-1,3-dione. Also disclosed are crystal forms of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a salt or solvate thereof and pharmaceutical compositions comprising same.

Abstract: The present invention is directed to a process for synthesizing an internal ketone K1 by decarboxylative ketonization reaction of a fatty acid, a fatty acid derivative or a mixture thereof in a liquid phase with a metal compound as catalyst in a reaction medium, said process being characterized in that a ketone K2 at liquid state, which is identical or similar to the ketone K1, is introduced into the reaction medium. The so-synthesized internal ketone K1 can be used for the preparation of a variety of end compounds, including surfactants having a twin-tail structure or a Gemini structure.

Abstract: [Problem] The present invention provides an industrially-preferable, cost-efficient, low-cost production method for 4-hydroxy-2-hydroxymethyl-2-cyclopenten-1-one (a compound represented by formula (I)) useful as a medicine, an agricultural chemical, or a raw material or intermediate of a medicine, an agricultural chemical, or the like. [Solution] According to the present invention, this compound represented by formula (I) is produced by subjecting an easily available compound represented by formula (II) (tri-O-acetyl-D-glucal) to a heating reaction in pressurized water.

Abstract: A production method for a cyclohexanedicarboxylic acid compound, having a step of obtaining a cyclohexanedicarboxylic acid compound or an aqueous ammonia solution of a cyclohexanedicarboxylic acid compound by bringing a phthalic acid compound in an aqueous ammonia solution into contact with hydrogen in the presence of a fixed bed catalyst in a reactor.

Abstract: The present disclosure provides method for isolating a long chain dicarboxylic acid such as a substantially pure or pure long chain dicarboxylic acid from a fermentation broth containing microbial cells.

Abstract: This invention provides compounds of Formulae (IA), (IB), (IC), (ID), (IE), (IF), (IG), (IH), (IJ), (IK), (IL), (II), (III), (IIIA), and (IIIB); pharmaceutically acceptable salts and solvates thereof; and compositions thereof.

Abstract: A process for esterification and/or trans-esterification, uses an acid as catalyst in the presence of an anionic surfactant.

Abstract: The present technology relates to synthesis of resveratrol compositions, in particular to methods of synthesizing resveratrol salicylates such as those formed through the activation of resveratrol and salicylic acid, and cosmetic and pharmaceutical compositions comprising the same.

Abstract: An object of the present invention is to provide a method for producing a fluorinated organic compound, whereby an iodosylbenzene derivative can be easily separated and recovered. The above object can be achieved by a method for producing a fluorinated organic compound, comprising step A of fluorinating an organic compound (1) by reaction with a fluorine source (3) in the presence of a hypervalent iodine aromatic ring compound (2a), or in the presence of an iodine aromatic ring compound (2b) and an oxidant (2bo); wherein the fluorine source (3) is a fluorine source (3a) represented by formula: MFn, wherein M is H, a metal of Group 1 of the periodic table, or a metal of Group 2 of the periodic table; and n is 1 or 2; and step B of separating the iodine aromatic ring compound from a reaction liquid after step A is started.

Abstract: The present disclosure relates to a method for preparing a crosslinker compound in which a crosslinker compound capable of using for the production of a super absorbent polymer can be obtained in a higher yield by a simple manner. The crosslinker compound obtained by the above method can be used as a thermally decomposable crosslinker in the process of producing a super absorbent polymer.

Abstract: The disclosure relates to a reversible adhesive composition including a copolymer between a vinyl spacer monomer unit and a vinyl reversible binder monomer unit. Each monomer unit can be based on acrylate monomer, a vinyl ester monomer, or a vinyl ether monomer, with the spacer monomer unit generally having a shorter pendant chain (such as 1-3 carbon atoms) and the reversible binder monomer unit having a longer pendant chain (such as 3-20 carbon atoms). A corresponding article includes first and second surfaces (or substrates) that are in contact with and bonded to the reversible adhesive composition at an interface therebetween. The reversible adhesive composition generally involves non-covalent and/or non-ionic bonding forces, for example H-bonding, permanent dipole, electron donor-acceptor moieties, and/or van der Waals forces, between the copolymer chains.

Abstract: The present invention relates to novel lignin-derived compounds and compositions comprising the same and their use as redox flow battery electrolytes. The invention further provides a method for preparing said compounds and compositions as well as a redox flow battery comprising said compounds and compositions. Additionally, an assembly for carrying out the inventive method is provided.

Abstract: The present invention provides a compound represented by the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof which can be effectively used for preventing or treating obesity or metabolic syndrome, and a pharmaceutical composition comprising the same. in Chemical Formula 1, R1 and R2 are the same as defined in the specification.

Abstract: The compound according to the present invention is a compound represented by the following chemical formula: wherein, in the above-described chemical formula, R1 is oxygen or sulfur, and R2 to R6 are each independently selected from hydrogen, an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, an acyl group having 1 to 6 carbon atoms and a nitro group.

Abstract: Provided is a production method for N-(?-alkoxyethylfrmamide, having a step (1) in which a basic catalyst stored in a catalyst supply device and formamide are mixed in a mixing tank; a step (2) in which the formamide mixed with the basic catalyst is brought in contact with acetaldehyde and N-(?-hydroxyethyl) formamide is obtained: and a step (3) in which the obtained N-(?-hydroxyethyl) formamide is brought into contact with an alcohol in presence of an acid catalyst and N-(?-alkoxyethyl)formamide is obtained. In step (1), at least part of the catalyst supply device is vibrated while the basic catalyst is supplied to the mixing tank.

Abstract: This invention is directed to compounds of Formula (I) pharmaceutically acceptable salts, esters, and prodrugs thereof, to their preparation, to pharmaceutical compositions comprising compounds of Formula I, and to their uses as antimicrobial agents.

Abstract: This invention provides novel 3-amino propanamide selective androgen receptor degrader (SARD) compounds, pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, androgenic alopecia or other 5 hyperandrogenic dermal diseases, Kennedy's disease, amyotrophic lateral sclerosis (ALS), and uterine fibroids, and to methods for reducing the levels of androgen receptor-full length (AR-FL) including pathogenic or resistance mutations, AR-splice variants (AR-SV), and pathogenic polyglutamine (polyQ) polymorphisms of AR in a subject.

Abstract: The invention relates to a method for recovering monomer diisocyanates, which are solid at room temperature, from a distillation residue, said method comprising the following steps: (i) preparing at least one residue which contains diisocyanates, which are solid at room temperature, and (ii) separating the residue in at least one kneader-dryer, paddle-dryer and/or roller-dryer in the presence of less than 2 wt % bitumen, based on the mass of the residue prepared in step (i), into a gaseous portion, containing monomer diisocyanate that is solid at room temperature, and a brittle residue depleted of diisocyanate, which is solid at room temperature.

Abstract: A urea production plant including a synthesis and recovery section has a first evaporation section connected with the synthesis and recovery section and a first condensation section. A granulation section is connected to the first evaporation section. A scrubbing section is connected to the granulation section. A second evaporation section is connected to the scrubbing section. The second evaporation section is connected to the granulation section. A second condensation section is connected to the second evaporation section. A quenching section includes a liquid inlet for the distribution of a quenching liquid is located and connected between the granulation section and the scrubbing section and the quenching section is connected to a quenching liquid providing section and the second condensation section.

Abstract: The present invention is directed to processes for the preparation of esketamine. The present invention is further directed to processes for the resolution of S-ketamine from a racemic or enantiomerically enriched mixture of ketamine. The present invention is further directed to an (S)-CSA salt of S-ketamine, more particularly a monohydrate form of the (S)-CSA salt of S-ketamine; and to an (R)-CSA salt of R-ketamine.

Abstract: Inhibitors of HBV replication of Formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein B, R1, R2 and R4 have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.

Abstract: The present invention relates to methods, formulations, and compositions for the treatment of biofilms. In particular, the application discloses isothiocyanate functional surfactants either alone or combination with adjunct agents to treat biofilms.

Abstract: This invention provides compound having a structure of Formulas: Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provide.

Abstract: The present invention relates to novel effective alkynyl-substituted 3-phenylpyrrolidine-2,4-diones according to the general formula (I) or agrochemically acceptable salts thereof, where X?C1-C4-alkyl, C1-C4-haloalkyl or C3-C6-cycloalkyl; Y?C1-C4-alkyl or C3-C6-cycloalkyl, n=1, 2 or 3; m=1 or 2; R1?C1-C6-alkyl, or C3-C6-cycloalkyl, R2=hydrogen or methyl; R3?C1-C3-alkoxy-C1-C3-alkyl, or a saturated five- or six-membered heterocycle with an oxygen or sulphur atom; G=hydrogen, a cleavable group L or a cation E. The invention also relates to the use of the compounds according to the invention for controlling weeds and weed grasses in crops of useful plants.

Abstract: The present disclosure relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. By comprising the organic electroluminescent compound of the present disclosure, an organic electroluminescent device having improved driving voltage, luminous efficiency, and/or lifespan characteristics can be provided.

Abstract: Disclosed are malate salts of N-(4-{[6,7-bis(methyloxy)-quinolin-4-yl]oxy}phenyl)-N?-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, including a (L)-malate salt, a (D)-malate salt, a (DL) malate salt, and mixtures thereof; and crystalline and amorphous forms of the malate salts. Also disclosed are pharmaceutical compositions comprising at least one malate salts of N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N?-(4-fluorophenyl)-cyclopropane-1,1-dicarboxamide; and methods of treating cancer comprising administering at least one malate salt of N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N?-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide.

Abstract: The present application provides compounds useful in methods of treating neurological disorders such as Alzheimer's disease, and cancer such as prostate cancer. Also provided herein are radiolabeled compounds useful for imaging techniques, and techniques for diagnosis and monitoring of treatment of neurological disorders and cancer. An exemplary radiolabeled compound provided herein is useful as a radiotracer for positron emission tomography or single-photon emission computed tomography. Methods for preparing radiolabeled compounds and methods for preparing unlabeled compounds are also provided.

Abstract: Benzyl derivative compounds having peroxisome proliferator-activated receptor ? (PPAR?) agonistic activity, compositions containing such compounds, and methods of their use in enhancing PPAR? activity for treating diseases and/or conditions involving inflammation and/or angiogenesis, particularly ocular diseases and/or conditions such as but not limited to retinal inflammation, retinal neovascularization, retinal vascular leakage, retinopathy of prematurity, diabetic retinopathy, age-related macular degeneration, and diabetic macular edema are disclosed.

Abstract: The present invention provides, inter alia, a process for producing a compound of Formula (I): wherein A1, R1, R2, R3, R4, R5 and R6 are as defined herein. The present invention further provides intermediate compounds utilised in said process, and methods for producing said intermediate compounds.

Abstract: The present invention relates to the compound of the formula: or pharmaceutically acceptable salts thereof, as well as compositions containing the same, processes for the preparation of the same, and therapeutic methods of use therefore in promoting hydration of mucosal surfaces and the treatment of diseases including chronic obstructive pulmonary disease (COPD), asthma, bronchiectasis, acute and chronic bronchitis, cystic fibrosis, emphysema, and pneumonia.

Abstract: A method for preparing 1,2,4-triazole includes using a fluoroborate aryl diazonium salt, a diazoester derivative and an organic nitrile as reaction substrates, a transition metal salt as a catalyst, and an inorganic base as an additive in a cyclization reaction. The method has the following characteristics: the reaction is economical; the substrate is universal; the post-functionalization is easy; the reaction conditions are mild; the reaction can be performed in air; the catalyst amount used is less; and the post-treatment is simple. Meanwhile, the raw materials, such as the reactants and the catalyst used, are inexpensive and easily available; the reaction composition is reasonable; no ligand is needed; there are less reaction steps; and only one step of reaction is required to obtain a high yield, meeting the requirements and directions of contemporary green chemistry and medicinal chemistry, being suitable for screening highly active 1,2,4-triazole drugs.

Abstract: Disclosed are dihydrobenzoxazinone compounds, dihydroquinolone compounds, and methods of their synthesis. The disclosed compounds may be prepared by reacting a benzoxazinedione compound and a ketone compound in the presence of an N-heterocyclic carbine (NHC) catalyst to perform a NHC-catalyzed decarboxylative cycloaddition. The disclosed compounds may be utilized to treat diseases and disorders associated with the biological activity of dihydrobenzoxazinone compounds and dihydroquinolone compounds.

Abstract: The present disclosure relates to a thiazole-5-carboxylic acid derivative represented by Formula (I), a stereoisomer and/or pharmaceutically acceptable salt thereof. The compound of Formula (I), the stereoisomer and/or pharmaceutically acceptable salt thereof of the present disclosure can be used to prepare a medicament for preventing or treating hyperuricemia and/or gout, and can be prepared into dosage forms for various administration routes. The compounds provided in the present disclosure have good tolerance, safety and excellent uric acid-lowering activity.

Abstract: The present invention relates to crystal modifications of 1,1-dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-(N—{(R)-?-[N—((S)-1-carboxypropyl)carbamoyl]-4-hydroxybenzyl}carbamoylmethoxy)-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine (odevixibat), more specifically crystal modifications 1 and 2 of odevixibat. The invention also relates to a process for the preparation of crystal modification 1 of odevixibat, to a pharmaceutical composition comprising crystal modification 1, and to the use of this crystal modification in the treatment of various conditions as described herein.

Abstract: Compounds that regulate quorum sensing in Staphylococcal bacteria and in particular in Staphylococcus aureus are provided. Compounds are described in formulas I, II, III, IV, V and VI herein. One or more compounds herein can be employed to inhibit QS and to thus inhibit virulence in Staphylococcus bacteria and in particular in Staphylococcus aureus. Compounds herein and pharmaceutical compositions containing one or more of these compounds are useful, for example, in treating infections of Staphylococcus bacteria and in particular of Staphylococcus aureus. Methods for treating such bacterial infections are provided.

Abstract: Cystine analogs that improve the solubility of L-cystine in urine for treatment of cystinuria and which have the structure: and pharmaceutically acceptable salts, solvates and prodrugs thereof, wherein each R and R? pair are independently selected from (i) or (ii); (i) R and R? are independently selected from hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alcohol, substituted or unsubstituted aryl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocyclic, and substituted or unsubstituted heteroaryl, or (ii) R and R? together form a substituted or unsubstituted heterocyclic ring structure, or a substituted or unsubstituted heteroaryl ring structure; X is hydrogen, or an alkyl; and Y is O or S.

Abstract: The present invention makes it possible to provide a method for producing a polyfunctional sulfur-containing epoxy compound, the method being characterized in that a polyfunctional thiol is reacted with an epihalohydrin in the presence of a reducing agent to form a polyfunctional sulfur-containing halohydrin, which is then reacted with a basic compound. The reducing agent is preferably at least one selected from the group consisting of sodium borohydride, lithium borohydride, lithium aluminum hydride, diisobutylaluminum hydride, and hydrazine.

Abstract: Provided are methods of producing carbonyl compounds (e.g., carbonyl containing compounds) and catalysts for producing carbonyl compounds. Also provided are methods of making polymers from carbonyl compounds and polymers formed from carbonyl compounds. A method may produce carbonyl compounds, such as, for example ?,?-disubstituted carbonyl compounds (e.g., ?,?-disubstituted ?-lactones). The polymers may be produced from ?,?-disubstituted ?-lactones, which may be produced by a method described herein.

Abstract: A process for producing furan dicarboxylic acid or an ester thereof from a feedstock comprising hydroxymethyl furfural (HMF) and humins is disclosed. Humins are a byproduct from reactions forming HMF from sugars and are typically removed from the HMF prior to any further processing. A humins-containing HMF feedstock is utilized to produce furan dicarboxylic acids and ester substantially free from humins.